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Abstract
Background: A relatively new uncalibrated arterial pressure waveform cardiac output (CO) measurement technique
is the Pulsioflex-ProAQT® system. Aim of this study was to validate this system in cardiac surgery patients with a
specific focus on the evaluation of a difference in the radial versus the femoral arterial access, the value of the auto-
calibration modus and the ability to show fluid-induced changes.
Methods: In twenty-five patients scheduled for ascending aorta, aortic arch replacement, or both we measured CO
simultaneously by transpulmonary thermodilution (COtd) and by using the ProAQT® system connected to the radial
(COpR), as well as the femoral artery catheter (COpF). Hemodynamic data were assessed at predefined time points;
from incision until 16 h after ICU admission.
Results: In total 175 (radial) and 179 (femoral) pairs of CO measurement were collected. The accuracy of COpR/
COpF was evaluated showing a mean bias of −0.31 L/min (±2.9 L/min) and -0.57 L/min (± 2.8 L/min) with
percentage errors of 49 and 46% respectively. Trending ability of the ProAQT® device was evaluated; the four
quadrant concordance rates in the radial and femoral artery were 74 and 75% and improved to 77 and 85% after
auto-calibration. The mean angular biases in the radial and femoral artery were 6.4° and 6.0° and improved to 5°
and 3.3° after auto-calibration. The polar concordance rates in the radial and femoral artery were 65 and 70% and
improved to 76 and 84% after auto-calibration. Considering the fluid-induced changes in stroke volume(SV), the
coefficient of correlation between the changes in SVtd and SVp was 0.57 (p < 0.01) in the radial artery and 0.60 (p <
0.01) in the femoral artery.
Conclusions: The ProAQT® system can be of additional value if the clinician wants to determine fluid
responsiveness in cardiac surgery patients. However, the ProAQT® system provided inaccurate CO measurements
compared to transpulmonary thermodilution. The trending ability was poor for COpR but moderate for COpF. Auto-
calibration of the system did not improve accuracy of CO measurements nor did it improve the prediction of fluid
responsiveness. However, the trending ability was improved by auto-calibration, possibly by correcting a drift over a
longer time period.
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Background
Goal-directed therapy (GDT) is a practice to achieve op-
timal tissue perfusion by optimizing hemodynamic pa-
rameters with responses to fluid resuscitation and
administration of inotropic and vasopressor medication.
GDT uses flow-directed hemodynamic parameters such
as stroke volume (SV) and the related cardiac output
(CO). GDT has been shown to improve patient outcome
by reducing morbidity and the length of stay on the in-
tensive care unit in high-risk patients undergoing major
surgery [1, 2].
In the peri-operative setting, clinicians are looking for
a system able to detect changes in CO over a longer
period of time to access the effect of fluid loading and
inotropic medication (trending ability). Traditionally, re-
peated thermodilution (td) is used for CO assessment in
an intrapulmonary or transpulmonary fashion (i.e.
PiCCO system). The latter system is validated in cardiac
surgery patients [3–6].
Several uncalibrated waveform analysis CO monitors
have been developed. Without thermodilution these de-
vices do not require central venous access and a special
arterial thermistor catheter in a large artery, and as such
are less invasive and more easily applicable. The uncali-
brated CO monitors have been investigated under vari-
ous clinical conditions. These validation studies showed
conflicting results regarding their reliability [7–11].
A relatively new uncalibrated CO monitoring device is
the ProAQT® sensor connected to the Pulsioflex monitor
(Pulsion, Maquet Getinge Group, Germany), hereafter
called the ProAQT® system. With this uncalibrated sys-
tem, it is relatively easy to promote the standard arterial
catheter pressure system to CO trend monitoring.
Studies comparing the ProAQT® system with calibrated
systems are rare in cardiac surgery patients [12–14]. A
limitation in these studies is the fact that the ProAQT®
sensor was connected to the femoral artery catheter while
the ProAQT® is supposed to be easily used at the radial
site.
The ProAQT® manufacturer advises to use the auto-
calibration mode that works by manual input. This is
based on software that estimates the aortic compliance
and systemic vascular resistance. Only one study investi-
gated this auto-calibration mode [13].
The aim of this study is to validate the ProAQT® CO
monitoring in major cardiac surgery patients prone to
hemodynamic fluctuations in the postoperative period.
For this purpose, the accuracy and the ability to track
changes in CO over time (trending ability) and in re-
sponse to a standard fluid challenge (fluid responsive-
ness) in radial and femoral artery are compared with the
PiCCO system.
We hypothesize that the uncalibrated pulse contour CO
measurement has a good trending ability, independent of
the arterial catheter site (i.e. radial or femoral artery). In
addition, the effect of the internal auto-calibration modus
will be assessed.
Methods
Patients and anesthesia
After obtaining approval from the Ethics Committee of
our hospital (MEC 2014-210) and written informed con-
sent from all patients, 25 patients were enrolled from
August 2014 to February 2016. This prospective, non-
interventional study was performed at the Departments
of Anesthesiology and Intensive Care Medicine of the
Erasmus Medical Center (Rotterdam, the Netherlands).
Patients were included if they were scheduled for dis-
tal ascending aorta or aortic arch replacement and
deep hypothermic circulatory arrest was expected to
be necessary during surgery. Prolonged cardiopulmo-
nary bypass time and deep hypothermic circulatory
arrest causes more hemodynamic fluctuations in the
postoperative period at the intensive care unit. We
hypothesized the clinician would have most benefit of
extra cardiac output monitoring in this specific pa-
tient group. Dual arterial pressure monitoring in this
type of cardiac surgery is standard care. Exclusion cri-
teria were age < 18 years old, emergency surgery, in-
tracardiac shunts and a contra-indication for femoral
artery catheterization.
Anesthesia, cardiac surgery and postoperative inten-
sive care management were performed according to
institutional standards. Before anesthesia was induced,
an arterial catheter (Flowswitch 20G, BD, USA or Lea-
dercath 20G, Vygon, UK) was inserted into the right
radial artery. If this artery was not accessible, a cath-
eter was placed in the right brachial artery. Thereafter
anesthesia was induced and a 16-cm 9,5 F five-lumen
central venous catheter (Arrow International Inc, Tel-
eflex Medical, Reading, USA) was inserted into the
right internal jugular vene. A PiCCO cold injectate de-
livery system (Pulsion, Maquet Getinge Group,
Germany) used for intermittent transpulmonary ther-
modilution was connected to the proximal lumen and
a pressure transducer was connected to measure cen-
tral venous pressure. A 20-cm 5 F thermistor-tipped
arterial catheter (Pulsiocath, Maquet Getinge Group,
Germany) was introduced via the left femoral artery.
This catheter was connected to a pressure transducer,
which was connected to the PiCCO monitor as well as
to another transducer system that was connected to a
Pulsioflex monitor (Pulsion, Maquet Getinge Group,
Germany). The arterial pressure catheter in the radial
artery was connected to a second Pulsioflex monitor.
Hemodynamic interventions, such as fluid loading and
cardiovascular drug support, were given at the discretion
of the attending anesthesiologist, in particular based on
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intra-operative transesophageal echocardiography and by
the intensivist in the postoperative period.
ProAQT® system
The ProAQT® system estimates CO with arterial pres-
sure waveform analysis. It needs the input of patient
data (age, gender, weight, height). To calculate CO,
the ProAQT® software uses the algorithm derived
from the PiCCO Pulse-Contour-Analysis technology.
The algorithm is based on the relationship between
area under the arterial pressure curve and stroke vol-
ume and a value quantifying vessel compliance and
peripheral resistance. Vessel compliance is estimated
based on demographic patient data and arterial resist-
ance is calculated from arterial waveform characteris-
tics [15, 16]. The system collects data with a high
sampling frequency of 250 Hz to provide beat-to-beat
CO monitoring.
The reference method
For adequate CO determination and the adjustment of
individual aortic compliance we used the PiCCO calibra-
tion method by transpulmonary thermodilution [17].
Study protocol
At each time point, three CO measurements were re-
corded simultaneously: COtd (using thermodilution
technique with the PiCCO system), COpR (using the
ProAQT® system connected to the radial artery) and
COpF (using the ProAQT® system connected to the fem-
oral artery). The thermodilution measurements (COtd)
were performed in triplicate with a sodium chloride
0.9% solution (20 mL, 4–6 °C) via the central venous
catheter [18]. The average of three measurements was
used for analysis. If the global end-diastolic volume
readings varied by more than 10%, one more thermodi-
lution measurement was performed and the extreme
one was excluded. During thermodilution measure-
ments, COpR and COpF were registered by a dedicated
observer, before and after activation of the internal auto-
calibration modus.
Measurements were performed at pre-defined time
points: after induction of anesthesia just before incision
(T0), after extracorporeal circulation and stabilized
hemodynamics (T1), after sternal closure (T2), on arrival
to ICU (T3), before a fluid challenge within 6 h after ad-
mission on the ICU (T4), immediately after this fluid
challenge (T5), 8 h after arrival on the ICU (T6) and
16 h after arrival on the ICU (T7). The fluid challenge
was defined as a bolus of more than 250 mL of fluid ad-
ministered in less than 15 min. All study measurements
were performed under stable hemodynamic conditions;
therefore no hemodynamic interventions were per-
formed during the CO collection period.
Statistical analysis
For data collection and statistical analysis, we used
SPSS (version 21; SPSS Inc., Chicago, IL, USA) and an
Excel spreadsheet (Microsoft Office Excel 2007, Micro-
soft Corp, USA). To generate the plots, we used the
open source statistical program RStudio using packages
(http://cran.r-project.org/) and Prism 6.0 (Graphpad
Software, La Jolla, California, USA). Based on the data
distribution visually inspected and tested with the
Shapiro-Wilk test, results were expressed as mean
(standard deviation) or median (interquartile range).
Repeated hemodynamic data were analysed by a test of
contrasts with a paired t test or the Wilcoxon signed
rank test, depending on data distribution, with a Bon-
ferroni correction for repeated testing.
To evaluate the accuracy of the ProAQT® device we
described the agreement between the paired data of
COp and COtd using the Bland-Altman analysis with
correction for multiple measurements per subject [19].
Subsequently, the percentage error (PE) was calculated
as 1.96xSD of the bias of the tested method divided by
the mean CO of the tested and the reference method ×
100% [20]. An acceptable PE and acceptable agreement
is recently discussed [21–23]. It depends on the error of
the reference method and the precision that is clinically
acceptable. The true error of the thermodilution refer-
ence method is unknown. We agreed with an acceptable
PE of maximal 30% set by Critchley et al. based on an
estimated precision of 20% for the thermodilution refer-
ence method and based on a clinically acceptable preci-
sion of less than 1 L/min for a mean cardiac output of
around 5 L/min [24].
To investigate the ability of the ProAQT® device to de-
tect serial changes in CO (i.e. trending ability), we used
the four quadrant plot and the polar plot approach [25,
26]. In the four-quadrant plots, the ProAQT® ΔCO is
plotted against the reference ΔCO. The four quadrant
concordance rate is defined as the percentage of the
number of data points that fall into 1 of the 2 quadrants
of agreement. At the center of the plot, data tend to be
randomly and not depending on the degree of agree-
ment between the reference and test method. Therefore,
exclusion zones for central data points are advised. In
our study we chose an exclusion zone of 0.75 L/min,
which is 12,5% of the mean CO [25]. A limitation in all
CO comparison studies is the lack of well-defined cutoff
values for good, acceptable and poor trending ability
based on concordance rates [27, 28]. As a guide, we
agreed with the best available cut off value which stated
a concordance rate with the use of an exclusion zone of
more than 92% indicates good trending ability [25, 26].
The polar plot analysis describes the vector of CO
change as an angle to the line of identity (x = y). In case
this angle is zero or 180°, the agreement of the two CO
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readings is 100%. The magnitude of change in CO is
represented as the average of the reference (PiCCO) and
the test (ProAQT®) cardiac output. We used the recom-
mended smaller exclusion zone of 10% in the polar plots
[25]. In our study this was set on 0.5 L/min. Two statis-
tical variables were derived from the polar data: (1) the
mean polar angle or angular bias, which is the average
angle between all polar data points and the horizontal
polar axis. The angular bias provides an assessment of
how well the test method is calibrated compared with
the reference method. Good calibration can be consid-
ered to exist when the angular bias is no greater than 5%
[25]. (2) The polar concordance rate, which is based on
the proportion of data points that lie within 30° of the
polar axis. A polar concordance rate of more than 95%
indicates good trending [25]. Because exclusion zones
are still a matter of debate and might hinder good com-
parison between different studies, we computed both the
concordance rates with and without excluding central
zone data.
Because Stroke Volume (SV) is a more pure predictor
of fluid responsiveness instead of CO we visualized
changes in SV before and after a fluid challenge. We de-
liberately did not use the above described statistical
methods to describe fluid induced changes because of
the small sample size (n = 22). Comparison of fluid-
induced changes in SV between thermodilution and the
ProAQT® measurement was made by the Spearman co-
efficient (chosen based on distribution of SV data). Cor-
relation coefficients were compared by using the Fisher
transformation. The change in SV in the ProAQT® sys-
tem was calculated by using the auto-calibrated SV data
before fluid bolus and both the auto- and non-calibrated
SV data after the fluid bolus. We defined fluid respon-
siveness as an increase in SV of more than 10% [29].
Results
Twenty-six patients were assesed for eligibility. Dur-
ing the total inclusion period 4 patients met the in-
clusion criteria but were not assessed for eligibility
because of absence of appropriate personel to perform
the measurements. No patient declined to participate,
one patient was excluded due to vascular prothesis in
both femoral arteries. Characteristics of the 25 en-
rolled patients and surgical procedures are shown in
Table 1. Of 196 COtd measurements collected, 13
were excluded because of aortic insufficiency prior to
surgical correction (aortic valve replacement). No
other CO data were excluded. There were 6 missing
COtd measurements due to human error. Two pa-
tients had an arterial catheter placed in the brachial
artery because the radial artery was not accessible. In
3 patients the radial artery catheter failed during the
ICU period resulting in a few missing measurements.
A total of 175 (radial) and 179 (femoral) pairs of CO
measurement were collected. The median collection
time for each data pair including tripled COtd meas-
urement was 149 (129–177) seconds.
Hemodynamic data are summarized in Table 2. The
CO values of the reference method (COtd) ranged from
2.6 to 9.9 L/min with an average of 5.9 (1.5) L/min for
the total study period. All patients received low dose
inotropic support with dobutamine and/or bolus enoxi-
mone and low dose vasopressor support with noradren-
aline the first hours after CPB. Vasopressor support with
noradrenaline was titrated based on a target blood
pressure.
Accuracy
Bland-Altman analysis corrected for repeated measure-
ments comparing ProAQT® CO measurements with
transpulmonary thermodilution CO measurement re-
vealed a small negative mean bias at almost all meas-
urement points. Internal calibration of the ProAQT®
monitor did not significantly change the mean bias nor
did it change the LoA. For the radial artery data, the
Table 1 Demographic data and surgical procedure
characteristics
Patient
Age (y) 67(9)
Male/Female 14/11
Weight(kg) 85(17)
Body Mass index (kg/cm2) 28(4)
Diabetic 3
Length of ICU stay (days) 1(1–2.3)
No valve dysfunction pre-operative 12
LVF
Good 20
Mildly decreased 5
Poor 0
Surgical procedure
Bentall procedure 2
Ascending aorta replacement 2
Hemi- or aortic arch replacement 12
Bentall and hemi-aortic arch replacement 9
Degree of hypothermia
18–24 °C 20
24–30 °C 1
30–37 °C 4
Operation time (min) 458(90)
Cardiopulmonary bypass time (min) 226(64)
Data are presented as the number, mean (SD) of median
(25th–75th percentile)
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mean bias between COtd and COpR was −0.31 L/min
with LoA of ± 2.9 L/min and a PE of 49%. For the fem-
oral artery data the mean bias between COtd and COpF
was −0.56 L/min with LoA of ± 2.8 L/min and a PE of
46%, as illustrated in Fig. 1. Bland-Altman analysis is
applied to compare the CO measurements of the radial-
and the femoral arterial access, both by using the
ProAQT® monitor. The mean bias was 0.25 L/min, LoA
± 1.9 L/min and PE 33%.
Trending ability
The four quadrant- and polar plots are shown in Figs. 2
and 3.
The four quadrant concordance rates in the radial and
femoral artery were 74 and 75% and improved to 77 and
85% after auto-calibration. In the polar plots, the mean
angular bias in the radial and femoral artery were 6.4°
and 6.0° and improved to 5° and 3.3° after auto-
calibration, respectively. Data points which fell within
the 30° limits (i.e. polar concordance rate) in the radial
and femoral artery were 65 and 70% and improved to 76
and 84% after auto-calibration.
Fluid responsiveness
In 22 of 25 patients a fluid challenge was given. Figure 4
shows changes in SV after this fluid bolus. Fluid respon-
siveness defined as an increase in SV of more than 10%
was found in 7 out of 22 patients based on the increase
in SV computed by transpulmonary thermodilution
(SVtd). The ProAQT® fluid responsiveness (SVp) agreed
in 20 out of 22 patients based on the SV calculation in
the radial artery and agreed in 21 out of 22 patients
based on the SV calculation in the femoral artery.
The coefficient of correlation between the fluid in-
duced changes in SVtd and SVp was 0.57 (p < 0.01) in
the radial artery data and 0.60 (p < 0.01) in the femoral
artery data. Auto-calibration of the ProAQT® system
after fluid administration deteriorated correlation in SV
changes in radial artery data and remained comparable
in femoral artery data (0.28 (p = 0.20) and 0.48 (p = 0.02),
respectively).
Fig. 1 Bland Altman plot. Bland-Altman plots show mean bias and 95% limits of agreement (LoA) in dashed lines. COtd, transpulmonary thermo-
dilution cardiac output assessed by the PiCCO system; COp, pulse contour cardiac output assessed by the ProAQT system. a Radial artery data be-
fore autocalibration. b Radial artery data after autocalibration. c Femoral artery data before autocalibration. d Femoral artery data
after autocalibration
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Discussion
Based on the results of our study, we conclude that the
uncalibrated pulse contour CO measurement is unreli-
able to estimate an absolute value of CO compared to
the transpulmonary thermodilution technique in major
cardiac surgery patients. In time, the overall trending
ability was moderate to poor. The auto-calibration
modus did not improve accuracy but it significantly im-
proved trending ability of the device. The best perform-
ance in trending ability was seen when the ProAQT®
monitor was connected to the femoral artery catheter
with the use of the auto-calibration modus. However,
the assessment of fluid responsiveness showed overall
good agreement.
Accuracy
Our results showed broad LoA and a high PE in the ra-
dial as well as the femoral artery CO measurement.
Smetkin et al. used a similar study protocol but their
CO measurements with the ProAQT® showed a clinical
acceptable accuracy with much smaller LoA [12]. They
observed a slight underestimation of the ProAQT® CO
measurements. Our data, except from the measurement
just after CPB, showed an overestimation of the
ProAQT® with a mean bias of 0.3 L/min in the radial ar-
tery and of 0.6 L/min in the femoral artery. Possible ex-
planation for these conflicting results could be a
difference in systemic vascular resistance after CPB and
hypothermia. Most of our patients underwent aortic
arch replacement having a long CPB time and deep
hypothermic arrest, while the patients in the study of
Smetkin underwent off pump coronary artery surgery
and remained normothermic.
Our study as well as two other validation studies
found a PE far above the 30% limits of acceptable agree-
ment which were recommended by Critchley et al. [24].
Fig. 2 Four Quadrant plot. Four quadrant plots: The serial changes in cardiac output measured with the ProAQT® (ΔCOp) are plotted against the
changes in cardiac output measured by thermodilution (ΔCOtd). The four quadrant concordance rate, defined as the percentage of the number
of data points that fall into 1 of the 2 quadrants of agreement are shown with and without making use of an exclusion zone (0.75 L/min)
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Monnet et al. measured before and after administration
of fluids or norepinephrine in intensive care patients and
observed an unacceptable high PE of 59% [13]. Broch et
al. evaluated the accuracy of the ProAQT® before and
after CPB. They also observed an unacceptable high PE
of 62% before and 49% after CPB [14]. There are some
statistical issues in the interpretation of PE. Manach et
al. stated the choice of up to 30% PE to be acceptable
limits of agreement is only realistic if the averaged ther-
modilution reference method has a good precision in
comparison with the real and variable CO, which cannot
be measured. Furthermore, PE calculation is influenced
by small sample size [23]. However, also if we do not
focus on the calculated PE but on the absolute
differences between ProAQT® CO data and our refer-
ence CO data, we suspect that these absolute differences
could lead to a relevant different treatment strategy in
clinical use. Therefore, we conclude that the ProAQT®
cannot reliably estimate absolute CO values in compari-
son to thermodilution.
Trending ability
An advantage of the ProAQT® device in daily ICU prac-
tice is that it does not require insertion of a special ar-
terial catheter or transducer system, it is easy to install
and results are obtained within a few minutes. For clin-
ical use, it is especially relevant if the system has the
ability to track changes in CO over a longer period of
Fig. 3 Polar Plot. Polar plots: Polar plot analysis describes the vector of CO change as an angle to the line of identity (x = y). In case this angle is
zero or 180°, the agreement of the two CO readings is 100%. The magnitude of change in CO is represented as the average of the reference
(PiCCO) and the test (ProAQT®) cardiac output (distance from the center). The exclusion zone is 0.5 L/min. Two statistical variables are shown
from the polar data: (1) the angular bias, which is the average angle between all polar data points and the horizontal polar axis. (2) The polar
concordance rate, which is the proportion of data points that lie within 30° of the polar axis (thick lines)
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time and thus has the ability to track changes in CO
after administration of a fluid bolus (i.e. fluid responsive-
ness). Despite the lack of clearly defined cut-off values
for definition of good, acceptable and poor trending abil-
ity, we found the overall concordance rates in the four
quadrant as well as in the polar plot to be moderate to
low. We conclude a poor trending ability of the
ProAQT® compared to transpulmanary thermodilution
in the radial artery and moderate trending ability in the
femoral artery. Our conclusion is in agreement with the
study of Smetkin. The authors conclude the ability of
the ProAQT® to follow trends in CO is poor [12]. The
study of Broch et al. revealed conflicting results. Their
four quadrant plots showed concordance rates indicating
acceptable trending ability, but their polar plot analysis
showed a poor trending ability [14]. However, the polar
plot method has some important drawbacks, as de-
scribed by Saugel [27]. Besides the fact that the plot is
not easy to interpret, the use of exclusion zones could
lead to the exclusion of relevant data points that are
most discordant. Despite the above-mentioned discus-
sion we agreed at this moment, the four quadrant plot
in combination with the polar plot method to be the
best available method to evaluate trending ability.
Fluid responsiveness
The trending ability of the ProAQT® after fluid adminis-
tration is remarkably better than the overall trending
ability of our CO data. The ProAQT® reliably followed
the changes in SV induced by a fluid bolus. These find-
ings are in agreement with the study of Monnet, in
which it was also concluded that the ability of the
ProAQT® to track fluid-induced changes was reliable
[13]. This is an important finding for clinical use. It is
relatively easy to enhance the standard arterial catheter
system with ProAQT® monitoring. With the ability to re-
liably track changes in SV after administration of a fluid
bolus, these extra hemodynamic data facilitate decision
making between inotropes, vasopressors and fluid ther-
apy. Especially if other post-operative measurements, for
example lactate, central venous saturation, urine produc-
tion, blood pressure or echocardiography measurements,
are inconclusive.
Femoral versus radial measurement site
According to the manufacturer, the ProAQT® algorithm
enables the use of arterial signals from different detec-
tion sites. Besides demographic patient data, the moni-
tor asks for input of the vascular access site. Because
the pulse pressure is a result of the SV and the proper-
ties of the vascular system between heart and the meas-
urement site, the software must somehow correct for
differences in vascular compliance and vascular resist-
ance to make a reliable CO calculation. The present
study showed that the accuracy of CO measurements
via the radial and femoral artery using the ProAQT®
sensor was not significantly different but the trending
ability was better when connecting the ProAQT® sensor
to the femoral artery catheter. The CO value from the
femoral artery catheter was on average 0.25 L/min
higher. These results are in agreement with other stud-
ies evaluating another type of pulse contour analysis
system using both a radial and a femoral arterial cath-
eter [10, 30, 31]. The difference between radial and
femoral data might be caused by variability in a central-
to-radial arterial pressure gradient as recently has been
analyzed by Fuda et al. [32]. In this study radial, fem-
oral and aortic pressures were measured in 73 cardiac
surgery patients. Normally, radial pulse pressure is
wider than aortic pulse pressure. This central-to-radial
Fig. 4 Fluid Responsiveness. Changes in stroke volume (SV) before (T4) and after (T5) a fluid bolus. We defined fluid responsiveness as an increase
in SV of more than 10%. The 7 thick lines are correlating with the data of the patients that were fluid responsive measured by transpulmonary
thermodilution (TPTD Responders). The ProAQT® fluid responsiveness agreed in most patients based on the pulse contour SV calculation in the
radial artery (middle figure) and in the femoral artery (right figure)
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pulse amplification depends on gradual stiffening of the
central elastic artery toward the peripheral muscular ar-
teries. Interestingly, almost half of cardiac surgery pa-
tients using CPB developed a reversed central-to-radial
pressure gradient. Furthermore, the gradient appear-
ance was dynamic in time and prolonged aortic clamp-
ing time was an independent predictor for the
development of this reversed gradient. Our patients
had a long CBP and aortic clamping time and this
might explain the better performance of the pulse
contour radial artery measurements in the off-pump
patient group [12].
A possible confounder in our study is the fact that the
ProAQT® software cannot correct for changes in pulse-
wave characteristics caused by placement of central
aorta vascular prosthesis. Another limitation is the fact
that we used a more centrally placed 20 cm long PiCCO
arterial catheter in the femoral artery. When we evalu-
ated the ProAQT® connected to the radial and femoral
artery data we did not only compare the ProAQT® sen-
sor and software corrections but also the different cath-
eter types. However, if we take this consideration into
account, our data suggest that the trending ability of the
pulse contour ProAQT® measurements connected to the
less invasive radial artery cannulation is not as good as
the pulse contour ProAQT® measurements when con-
necting the sensor to the thermodilution femoral
catheter.
Auto-calibration
Auto-calibration is a software mode that estimates the
aortic compliance and systemic vascular resistance based
on a combination of patient data and specific character-
istics of the shape of the pressure waveform.
Based on these data the software can make a recalcu-
lation of the pulse contour analysis data. This calibration
is not performed automatically, but works on demand by
manual input. We questioned if auto-calibration of the
ProAQT® system improved accuracy and trending ability.
Our data showed that auto-calibration improved trending
ability in both the radial and the femoral artery but it did
not improve the accuracy of the CO measurements. Con-
versely, Monnet et al. found that auto-calibration did not
improve the trending ability [13]. A reason for these con-
flicting findings might be the fact that Monnet et al. stud-
ied changes in CO in a shorter period of time (10 min
versus several hours in our study). In our study, 20 out of
25 patients received hypothermic arrest (18 –24 °C). In
the postoperative period the measured systemic vascular
resistance increased over a longer period of time. These
conflicting results could be an argument for further stud-
ies determining the effect of the auto-calibration modus
over longer periods of time and related to changes in vas-
cular resistance.
Conclusions
The ProAQT® system can be of added value if the clin-
ician is questioning fluid responsiveness in major cardiac
surgery patients. However, we observed inaccurate abso-
lute CO measurements with this pulse contour monitor-
ing system compared to transpulmonary thermodilution.
Trending ability of the ProAQT® was poor when the de-
vice was connected to the radial artery and improved to
moderate trending ability when it was connected to the
femoral artery. Auto-calibration of the system did not
improve the accuracy of CO measurements and did not
improve prediction of fluid responsiveness but it did im-
prove the trending ability, possibly by correcting a drift
over a longer time period.
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